For the first time, the evidence on maternal immunisation is being led from the countries where the burden is highest.
Researchers, partners and collaborators from the MIRNA countries share what the meeting meant for them as preliminary results come in across the work packages: burden of disease, health economics, vaccine demand and situational analysis.
